Shanghai, China

Shunwei Zhu

This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Simcere Pharmaceutical Co., Ltd., Simcere Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shunwei Zhu. Retrieved from https://idiyas.com/inventor/shunwei-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shunwei Zhu: Innovator in Cerebral Stroke Treatment

Introduction

Shunwei Zhu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of cerebral strokes. His innovative approach has led to the development of a unique composition aimed at improving patient outcomes.

Latest Patents

Shunwei Zhu holds 1 patent for his work titled "Use of composition in treatment of cerebral stroke." This patent describes a composition that includes edaravone and dexborneol, specifically designed for treating patients suffering from cerebral strokes, especially those with a history of hypertension.

Career Highlights

Throughout his career, Shunwei Zhu has worked with prominent companies in the pharmaceutical industry. He has been associated with Simcere Pharmaceutical Co., Ltd. and Jiangsu Simcere Pharmaceutical Co., Ltd., where he has contributed to various research and development projects.

Collaborations

Shunwei Zhu has collaborated with several professionals in his field, including Xiaofei Feng and Cuncun Liu. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Shunwei Zhu's contributions to the treatment of cerebral strokes highlight his dedication to medical innovation. His work continues to impact the lives of patients and the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…